Search

Your search keyword '"ANTIMALARIALS"' showing total 20,320 results

Search Constraints

Start Over You searched for: Descriptor "ANTIMALARIALS" Remove constraint Descriptor: "ANTIMALARIALS" Topic malaria Remove constraint Topic: malaria
20,320 results on '"ANTIMALARIALS"'

Search Results

1. Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity.

2. Incompatibility of antimalarial drugs: challenges in formulating combination products for malaria.

3. Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents.

4. Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times.

5. Comparison of extraction methods in vitro Plasmodium falciparum: A 1 H NMR and LC-MS joined approach.

6. Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania.

7. Brazilian plants with antimalarial activity: A review of the period from 2011 to 2022.

8. Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.

9. Factors impacting sustained coverage in the context of donor transitions: experience from Sri Lanka.

10. Blood-stage antimalarial activity, favourable metabolic stability and in vivo toxicity of novel piperazine linked 7-chloroquinoline-triazole conjugates.

11. Marmesin isolated from Celtis durandii Engl. root bioactive fraction inhibits β-hematin formation and contributes to antiplasmodial activity.

12. Diarylpentanoids, the privileged scaffolds in antimalarial and anti-infectives drug discovery: A review.

13. Identification of potential inhibitors of casein kinase 2 alpha of Plasmodium falciparum with potent in vitro activity.

14. Development of diphenylmethylpiperazine hybrids of chloroquinoline and triazolopyrimidine using Petasis reaction as new cysteine proteases inhibitors for malaria therapeutics.

15. The public health response to a Plasmodium malariae outbreak in Penampang district, Sabah during a COVID-19 movement control order.

16. Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.

17. Rebound of multiple infections and prevalence of anti-malarial resistance associated markers following malaria upsurges in Dielmo village, Senegal, West Africa.

18. Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.

19. Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.

20. Human blood neutrophils generate ROS through FcγR-signaling to mediate protection against febrile P. falciparum malaria.

21. Biological activity of 1,2,3-triazole-2-amino-1,4-naphthoquinone derivatives and their evaluation as therapeutic strategy for malaria control.

22. Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?

23. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.

24. Plasmodium falciparum Gametes and Sporozoites Hijack Plasmin and Factor H To Evade Host Complement Killing.

25. Toxins from Animal Venoms as a Potential Source of Antimalarials: A Comprehensive Review.

26. Antenatal interventions to reduce risk of low birth weight related to maternal infections during pregnancy.

27. Acceptability of short message service (SMS) as a tool for malaria treatment adherence in the Brazilian Amazon: a qualitative study.

28. Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope.

29. Pre-referral rectal artesunate is no "magic bullet" in weak health systems.

30. Left ventricular function by strain in uncomplicated malaria: a prospective study from the Brazilian Amazon.

31. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.

32. Artemether-lumefantrine, mefloquine and atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria in travellers: A retrospective comparative study of efficacy and treatment failures.

33. In vivo antiplasmodial activities of stem bark extracts of Avicennia marina in Plasmodium berghei -infected mice.

34. Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature.

35. [Laveran and the eradication of malaria in Corsica].

36. Synergistic antimalarial treatment of Plasmodium berghei infection in mice with dihydroartemisinin and Gymnema inodorum leaf extract.

37. A severe case of Plasmodium falciparum malaria imported by a French traveler from Cameroon to French Guiana despite regular intake of Artemisia annua herbal tea.

38. Barriers and facilitators to nationwide implementation of the malaria vaccine in Ghana.

39. N-sulfonylpiperidinedispiro-1,2,4,5-tetraoxanes exhibit potent in vitro antiplasmodial activity and in vivo efficacy in mice infected with P. berghei ANKA.

40. Inequalities in the use of insecticide-treated nets by pregnant women in Ghana, 2011 and 2017.

41. Non-falciparum species and submicroscopic infections in three epidemiological malaria facets in Cameroon.

42. Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia.

43. In vitro antiplasmodial activity-directed investigation and UPLC-MS fingerprint of promising extracts and fractions from Terminalia ivorensis A. Chev. and Terminalia brownii Fresen.

44. Antimalarial Efficacy of Aqueous Extract of Strychnos ligustrina and Its Combination with Dihydroartemisinin and Piperaquine Phosphate (DHP) against Plasmodium berghei Infection.

45. Epidemiology and clinical features of imported malaria: a 14-year retrospective single-centre descriptive study in Prague, Czech Republic.

46. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.

47. Community-Based Malaria Testing Reduces Polypharmacy in a Population-Based Survey of Febrile Illness in Western Kenya.

48. Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales.

49. Direct type I interferon signaling in hepatocytes controls malaria.

50. Advancing Key Gaps in the Knowledge of Plasmodium vivax Cryptic Infections Using Humanized Mouse Models and Organs-on-Chips.

Catalog

Books, media, physical & digital resources